Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine.
about
The Use of Synthetic Carriers in Malaria Vaccine DesignComparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future NeedsIn vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticlesRecent advances in recombinant protein-based malaria vaccines.MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles.Adjuvants in micro- to nanoscale: current state and future direction.Small Wonders-The Use of Nanoparticles for Delivering Antigen.Design of nanomaterial based systems for novel vaccine development.Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development.Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity.Tannic Acid-Modified Silver and Gold Nanoparticles as Novel Stimulators of Dendritic Cells Activation.Nanoparticle Vaccines Against Infectious Diseases
P2860
Q26777053-DA046D47-9F8E-4A39-A03D-1125F80F68BEQ36191001-B4992D89-2224-4E3D-8124-11453820A9C2Q36289257-0592D751-E1C0-4819-8D3F-1D2B6D7D54E1Q36394182-5B12688C-CE6A-4275-8D7A-FE37B2CBB900Q37671607-58F6C547-E1F8-4909-868B-439BFC854AC7Q38520210-687E4330-87BD-4A5C-87BF-A73549BFD6D4Q38583148-DBAA84C3-8612-4B95-8D6E-02D463D8AB9DQ38739675-205EC23A-DBED-4A5C-8C78-25D5C1502E74Q39197667-726F0161-4F94-4253-84B8-F5715415FE5FQ47251697-51BA2290-58F6-486B-9B60-0F84E9FD9B76Q55000182-71110692-86CD-4662-845C-39184FB46DF9Q58583890-6946DB19-1139-49B5-9898-11CEA5627A73
P2860
Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Iron oxide nanoparticles as a ...... d-stage human malaria vaccine.
@ast
Iron oxide nanoparticles as a ...... d-stage human malaria vaccine.
@en
type
label
Iron oxide nanoparticles as a ...... d-stage human malaria vaccine.
@ast
Iron oxide nanoparticles as a ...... d-stage human malaria vaccine.
@en
prefLabel
Iron oxide nanoparticles as a ...... d-stage human malaria vaccine.
@ast
Iron oxide nanoparticles as a ...... d-stage human malaria vaccine.
@en
P2093
P2860
P356
P1433
P1476
Iron oxide nanoparticles as a ...... d-stage human malaria vaccine.
@en
P2093
Andrew Wang
George Hui
Jaclyn McLoughlin
Mazie Tsang
Sophie Kobuch
Zoraida Aguilar
P2860
P304
P356
10.1096/FJ.12-218362
P407
P577
2012-11-29T00:00:00Z